shares of Neurobo Pharmaceuticals Inc (NRBO) on
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company is headquartered in Ann Arbor, Michigan and currently employs 9 full-time employees. The firm is focused on developing pharmaceuticals to treat neurodegenerative disorders. The firm is addressing unmet needs in patients with Painful Diabetic Neuropathy (PDN) and Alzheimer’s disease. The Company’s product candidate, NB-01, is targeting neuropathic pain with an indication in PDN. The firm also provides NB-02, which is an Alzheimer’s and tauopathies drug.